A joint effort of the American Society of Hematology (ASH) and the European Hematology Association (EHA), Translational Research Training in Hematology (TRTH), is a unique, year-long training and mentoring program focused on helping early-stage researchers, including senior postdoctoral fellows and junior faculty, gain the tools necessary to build successful careers in blood-related translational research. Trainees and faculty holding MDs, MD/PhDs, biomedical PhDs, or pharmacy PharmDs (or equivalents) are encouraged to apply.
Each year, 20 early-career scientists (10 from North America and 10 from Europe) are selected to participate in this prestigious and rigorous training program, which is led by faculty who are international leaders in hematology. Topics covered include biostatistics and biomarkers, genetics and molecular biology, ethics, and phase I clinical study design.
TRTH includes an intensive week-long course held in the spring and year-long mentoring interactions with experts in the field. During the spring course, which will take place in France in 2023, mornings will be dedicated to research seminar-style interactive sessions on translational research methodology, cutting-edge technology, ethics in hematologic research, and career development. Afternoons will be devoted to small group sessions in which participants will meet with their TRTH mentors, peers, and faculty to refine their individual research proposals and hone their scientific presentation and communication skills. Informal presentations by leaders in hematology, designed to illustrate the variety of pathways to a successful career in blood-related, lab-based research, will take place in the evenings.
After the initial course, follow-up mentoring meetings occur throughout the year at the EHA Congress and the ASH Annual Meeting and Exposition. These meetings provide additional opportunities for TRTH participants to refine their research proposals through small group mentoring sessions and to interact with mentors and peers. At the final meeting, trainees present on the status of their research projects and careers.
How to Apply
TRTH has a two-step application process, which begins with the submission of a letter of intent (LOI). Only those who meet the LOI requirements will be invited to submit a full application.
Interested applicants must fill out the required LOI template, which can be accessed through EHA’s website at ehaweb.org/research/training-and-mentoring, and get it signed by their selected mentor.
Once completed, LOI forms can be submitted through the EHA Portal at eha.fluxx.io. Applicants will be prompted to create an account if they do not already have one.
The deadline to submit an LOI for the 2023 TRTH cohort is June 23 at 9:00 a.m. Eastern time.
For more information on TRTH, including full eligibility requirements and restrictions, please visit hematology.org/awards/career-enhancement-and-training.
